0
Business
How Ketamine Spawned a $1.7 Billion J&J Blockbuster Drug
April 30, 2026
Scroll
Posted 2 hours ago by
Spravato, the ketamine-derived nasal spray from Johnson Johnson, was once seen as a long shot. It was difficult to deliver, heavily regulated and slow to catch on. Find out how it became a billion-dollar drug and part of a new model for treating depression. (Source: Bloomberg)
Bloomberg
Coverage and analysis from United States of America. All insights are generated by our AI narrative analysis engine.
United States of America
Bias: lean left
People's Voices (0)
Leave a comment
0/500
Note: Comments are moderated. Please keep it civil. Max 3 comments per day.